Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells
Huiling Zhou(Shanghai Institute of Materia Medica), Haidan Liu(Ministry of Natural Resources)
Cited by 29
Related Papers
Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth
|EBioMedicine|2019|89
Oxymatrine inhibits non–small cell lung cancer via suppression of <scp>EGFR</scp> signaling pathway
|Cancer Medicine|2017|59
Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization
|Cell Death and Disease|2020|58